PEP-030

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NamePEP-030
Drug Alias NameDPT-PEP2PEP-030
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionRAF serine/threonine protein kinase inhibitorsGTPase Ras inhibitors
TargetsRAF serine/threonine protein kinaseGTPase Ras
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPEP-Therapy
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPEP-Therapy
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A